Instrumento Inactivo

Acciones Cascadian Therapeutics Inc (USA) Nasdaq

Acciones

Duración

Período

Estilo

Cascadian Therapeutics Announces 2018 Outlook and Recent Progress	04/01/18
Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency	02/01/18
Cascadian Therapeutics Added to the Nasdaq Biotechnology Index	13/12/17
Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer	07/12/17
Cascadian Therapeutics Reports Third Quarter 2017 Financial Results	08/11/17

Sector

	Varia. 1 de ene.	Capi.
REGENERON PHARMACEUTICALS, INC.	+8,96 %	105 mil M
VERTEX PHARMACEUTICALS INCORPORATED	-1,43 %	104 mil M
ARGENX SE	+5,24 %	22,94 mil M
BIONTECH SE	-12,15 %	22,34 mil M
GENMAB A/S	-6,91 %	19,25 mil M
WUXI APPTEC CO., LTD.	-39,98 %	17,08 mil M
BEIGENE, LTD.	-10,04 %	16,96 mil M
SAREPTA THERAPEUTICS, INC.	+38,61 %	12,63 mil M
VIKING THERAPEUTICS, INC.	+313,59 %	8487,34 M